— Know what they know.
Not Investment Advice

YDES

YD Bio Limited Ordinary Shares
1W: +42.6% 1M: -8.3% 3M: -36.1% YTD: -35.6%
$7.81
+0.08 (+1.03%)
After Hours: $7.87 (+0.06, +0.70%)
NASDAQ · Healthcare · Biotechnology · $545.1M · Alpha Radar Strong Sell · Power 34
Smart Money Score
No convergence signal
Key Statistics
Market Cap$545.1M
52W Range5.3-25
Volume11,855
Avg Volume36,298
Beta0.17
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOEthan Shen
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2025-08-29
No. 3, Xingnan St.
Taipei 115001
TW
About YD Bio Limited Ordinary Shares

Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.

Recent Insider Trades

NameTypeSharesPriceDate
Hen Man Edmund 0 2026-03-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms